Markus Trujillo, MA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 67a Mountain Boulevard Ext., 1st Floor, Unit B, Warren, NJ 07059 Phone: 858-216-8837 |
News Archive
Cutting pharmaceutical prices will severely reduce the number of new medications making it to market, according to a groundbreaking independent study from ESMT Competition Analysis. For the first time, the study on 'Pharmaceutical Innovation and Pricing Regulation' clearly models and quantifies the direct link between strict regulation and low innovation.
Patients battling cancer have a better experience of care at hospitals that employ more cancer specialist nurses.
Advertisements on television and in newspapers consistently hype the latest diet fads. News reports comment on the latest research about the negative effects of obesity on Americans.
Subtle cognitive dysfunction and decline in breast cancer patients was largely independent of chemotherapy but associated with cancer-related post-traumatic stress in a German multisite study.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SUTENT® (sunitinib malate) as the first anti-VEGF therapy to treat progressive, well-differentiated pancreatic neuroendocrine tumors (NET) in patients with unresectable locally advanced or metastatic disease. Pancreatic NET is a rare cancer reported in two to four people per million annually worldwide.
› Verified 8 days ago